We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study.
- Authors
van Leth, F; Phanuphak, P; Ruxrungtham, K; Baraldi, E; Miller, S; Gazzard, B; Cahn, P; Lalloo, U G; van der Westhuizen, I P; Malan, D R; Johnson, M A; Santos, B R; Mulcahy, F; Wood, R; Levi, G C; Reboredo, G; Squires, K; Cassetti, I; Petit, D; Raffi, F; Katlama, C; Murphy, R L; Horban, A; Dam, J P; Hassink, E; van Leeuwen, R; Robinson, P; Wit, F W; Lange, J M A; 2NN Study team
- Abstract
The 2NN Study was a randomised comparison of the non-nucleoside reverse-transcriptase inhibitors (NNRTI) nevirapine and efavirenz.
- Publication
Lancet (London, England), 2004, Vol 363, Issue 9417, p1253
- ISSN
1474-547X
- Publication type
Journal Article
- DOI
10.1016/S0140-6736(04)15997-7